Can biotechnology dramatically extend human health and lifespan? In Episode 4 of Live Long Live Well, Steve Loyd, CEO of Galahad Life Sciences, explains the philosophy and guiding principles behind Galahad's approach to longevity science and biotechnology innovation. After leaving a successful career in finance and academia in his mid-50s, Steve dedicated his life to one mission: slowing and ultimately reversing biological aging so humans can live longer, healthier lives—potentially reaching 200 years of vibrant health. To pursue this ambitious goal, Steve developed a new framework for biotechnology discovery built on three core principles designed to challenge the traditional medical model.
This episode explores:
• Why Steve believes the current healthcare model is inefficient and outdated
• The personal health crisis that pushed him into biotechnology
• Galahad's three guiding rules for discovery and innovation
• Why the principle "First, Do No Harm" must guide biotechnology development
• How breakthroughs often occur between disciplines, not within them
• Why evolutionary biology offers powerful clues for solving modern health challenges
• How new biotech approaches may improve cellular vitality and mitochondrial function
Steve also shares how Galahad brings together expertise from multiple fields—including biotechnology, engineering, materials science, and evolutionary biology—to create safer, more effective solutions that improve human healthspan. The mission of Galahad Life Sciences is simple but ambitious: Help humans live longer, healthier, and more vibrant lives.
Future episodes will feature conversations with leaders across disciplines, including: • Biotechnology • Medicine • Biology • Nutrition and exercise science • Evolutionary biology • Psychology and behavioral science. All focused on understanding and addressing one of humanity's biggest challenges: Aging.
